We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · July 24, 2020

ACE Inhibitors/ARBs Are Associated With Lower Colorectal Cancer Risk

Hypertension

 

Additional Info

Hypertension
ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk: A Territory-Wide Study With Propensity Score Analysis
Hypertension 2020 Jul 06;[EPub Ahead of Print], KS Cheung, EW Chan, WK Seto, ICK Wong, WK Leung

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading